StockData
IGC Pharma, Inc. logo

IGC Pharma, Inc. (IGC) stock

IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/309% above fair value
$0.18−0.01 (-4.61%)

Close on Nov 13, 2026Market cap $18.20MP/E –Yield –

Earnings

IGC Pharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of IGC Pharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2012ended Jun 30, 2011Jul 15, 2011during market hours–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

IGC Pharma has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When IGC Pharma puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases IGC Pharma filed with the SEC as exhibits to Form 8-K or 6-K

  1. 8-K exhibit EX-99.1
    Update
  2. Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness
    News
  3. IGC Pharma Announces Results of 2025 Annual
    News
  4. Date: June 16, 2025 NYSEAmerican: IGC 1 NYSE AMERICAN: IGC - Service to humanity -
    News
  5. IGC Announces Results of its 2024 Annual Stockholders Meeting
    News
  6. IGC Pharma Announces Positive Interim Results for IGC-AD1 in
    Update
  7. PRESS RELEASE ISSUED ON MARCH 26, 2024
    News
  8. IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer ’ s Pipeline
    Update
  9. IGC Announces Results of its 2023 Annual Stockholders Meeting
    News
  10. IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.
    Update
  11. 8-K exhibit EX-99.1
    Update
  12. IGC Announces Updated Life Sciences Presentation
    Update
  13. IGC Announces Results of its 2022 Annual Stockholders Meeting
    News
  14. IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
    News
  15. India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement
    News

See a number that looks wrong?